News for Seegene, Inc. (096530.KQ)

Seegene, Microsoft, & Springer Nature unite to harness AI & PCR tech, bolstering health infrastructure & pandemic readiness for a disease-free world.

Sepsis diagnostics market has emerged as a rapidly growing area due to the high prevalence of sepsis and advancement in diagnostic technology. There is a...

Infectious Disease Diagnostics Market size was valued at USD 22.94 billion in 2023 to USD 43.09 billion by 2031...

For years, the South Korean exchange sought to lure investors to its single-stock options with little success. That’s starting to change.

Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene's technology-sharing initiative The two companies will co-establish a NewCo in Spain to serve as a strategic hub in Europe, accelerating global expansion of the initiative Localization of Seegene's syndromic real-time PCR product development and manufacturing will bring diagnostic products specifically tailored to the needs of the local market SEOUL, South Korea, Oct. 8, 2024 /PRNewswire/ -- Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, announced today the finalization of a partnership agreement with Werfen, a worldwide leader in specialized diagnostics, on the technology-sharing initiative. Under the agreement, Seegene and Werfen will set up a NewCo in Spain, Werfen-Seegene, upon the conclusion of mandatory government approvals anticipated by the first half of 2025.

Introduces Novaplex™ MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has higher transmission and mortality rates than Clade II Adheres to the WHO issued target product profiles and provides accurate detection of viral strains Offers healthcare professionals with a critical tool in their research on the global spread of mpox by supporting international efforts SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Seegene Inc., a leading provider of total solution for PCR molecular diagnostics based in South Korea, announced today that it will introduce a new type of research-use-only (RUO) PCR assay to address the spread of the mpox virus variant, Clade Ib, which is currently prevalent in Africa.

Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays

New-age Vaccines Warrant Wide Applicability of Cell Culture! FMI Predicts Favorable Forecast Period for Key Players Despite Waning CAGR. ...

- Exhibited multiplex PCR testing technologies that provide comprehensive results from a single test

Fear of Evolving COVID Variants and Ability to Detect Multiple Diseases Increasing Use of Polymerase Chain Reaction Technologies: Fact.MR Report...

Chicago, July 18, 2024 (GLOBE NEWSWIRE) -- The

/PRNewswire/ -- Frost & Sullivan Institute is proud to present the prestigious Enlightened Growth Leadership Awards, 2023, honoring organizations that embody a...

/PRNewswire/ -- In the near future, the CT/NG (Chlamydia and Gonorrhea) testing industry is poised to witness significant advancements and transformations....

According to DelveInsight's’ estimates, the sepsis market in 7MM is expected to show good positive growth, during the forecast period (2023–2032), mainly...

/PRNewswire/ -- The

/PRNewswire/ -- The "South Korea In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players...

/PRNewswire/ -- The

/PRNewswire/ -- The "HPV Testing and Pap Test Market by Test Type (HPV Testing (Follow-Up HPV Testing, Co- Testing, Primary HPV Testing), PAP Test), End User...

/PRNewswire/ -- The Frost & Sullivan Institute is dedicated to utilizing business practices to address key global challenges by 'innovating to zero'. Through...